Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins - PubMed (original) (raw)
. 2007 Jul;28(7):1552-60.
doi: 10.1093/carcin/bgm075. Epub 2007 Apr 2.
Affiliations
- PMID: 17404395
- DOI: 10.1093/carcin/bgm075
Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins
A Budhu et al. Carcinogenesis. 2007 Jul.
Abstract
Hepatocellular carcinoma (HCC) is a fatal disease and hepatitis B and C viruses (HBV and HCV) are considered as major causative factors for the development of HCC. We have conducted gene expression profiling studies to search for potential target genes responsible for HCV-mediated HCC. Adenoviruses encoding core (HCV structural protein), NS3 and NS5A [HCV non-structural (NS) proteins] were generated and infected individually or together in freshly isolated primary human hepatocytes. An adenovirus harboring the oncogenic HBV protein, HBx, was included for comparison. A microarray platform of over 22,000 human oligos was analyzed to seek out significant differentially expressed genes among these viral proteins. We also compared these gene expression profiles with those obtained from HCV-infected liver samples from chronic liver disease (CLD) patients and HCV-related HCC. We found that HCV-related proteins largely induce unique genes when compared with HBx. In particular, interferon-inducible gene 27 (IFI27) was highly expressed in HCV or core-infected hepatocytes and HCV-related CLD or HCC, but was not significantly expressed in HBx-infected hepatocytes or HBV-related CLD or HCC, indicating that IFI27 may play a role in HCV-mediated HCC. In conclusion, our results suggest that HBV and HCV promote HCC development mainly through different mechanisms.
Similar articles
- Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.
El-Shamy A, Shindo M, Shoji I, Deng L, Okuno T, Hotta H. El-Shamy A, et al. Hepatology. 2013 Aug;58(2):555-63. doi: 10.1002/hep.26205. Epub 2013 Jun 14. Hepatology. 2013. PMID: 23281009 - Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA.
Zhang J, Ishigaki Y, Takegami T. Zhang J, et al. Mol Med Rep. 2015 Oct;12(4):5109-15. doi: 10.3892/mmr.2015.4041. Epub 2015 Jul 3. Mol Med Rep. 2015. PMID: 26151503 - Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A, Fujita K, Iwama H, Chiyo T, Fujihara S, Oura K, Tadokoro T, Mimura S, Nomura T, Tani J, Yoneyama H, Kobayashi K, Kamada H, Guan Y, Nishiyama A, Okano K, Suzuki Y, Himoto T, Shimotohno K, Masaki T. Morishita A, et al. Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G401-G409. doi: 10.1152/ajpgi.00269.2019. Epub 2020 Jan 6. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 31905024 - The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways.
Sartorius K, Swadling L, An P, Makarova J, Winkler C, Chuturgoon A, Kramvis A. Sartorius K, et al. Viruses. 2020 Jul 10;12(7):746. doi: 10.3390/v12070746. Viruses. 2020. PMID: 32664401 Free PMC article. Review. - Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
Ali A, Abdel-Hafiz H, Suhail M, Al-Mars A, Zakaria MK, Fatima K, Ahmad S, Azhar E, Chaudhary A, Qadri I. Ali A, et al. World J Gastroenterol. 2014 Aug 14;20(30):10238-48. doi: 10.3748/wjg.v20.i30.10238. World J Gastroenterol. 2014. PMID: 25132741 Free PMC article. Review.
Cited by
- Prediction of Key Candidate Genes for Platinum Resistance in Ovarian Cancer.
Guo K, Li L. Guo K, et al. Int J Gen Med. 2021 Nov 16;14:8237-8248. doi: 10.2147/IJGM.S338044. eCollection 2021. Int J Gen Med. 2021. PMID: 34815697 Free PMC article. - RNA Sequencing of Hepatobiliary Cancer Cell Lines: Data and Applications to Mutational and Transcriptomic Profiling.
Scherer D, Dávila López MD, Goeppert B, Abrahamsson S, González Silos RG, Nova I, Marcelain K, Roa JC, Ibberson D, Umu SU, Rounge TB, Roessler S, Bermejo JL. Scherer D, et al. Cancers (Basel). 2020 Sep 3;12(9):2510. doi: 10.3390/cancers12092510. Cancers (Basel). 2020. PMID: 32899426 Free PMC article. - Refinement of light-responsive transcript lists using rice oligonucleotide arrays: evaluation of gene-redundancy.
Jung KH, Dardick C, Bartley LE, Cao P, Phetsom J, Canlas P, Seo YS, Shultz M, Ouyang S, Yuan Q, Frank BC, Ly E, Zheng L, Jia Y, Hsia AP, An K, Chou HH, Rocke D, Lee GC, Schnable PS, An G, Buell CR, Ronald PC. Jung KH, et al. PLoS One. 2008 Oct 6;3(10):e3337. doi: 10.1371/journal.pone.0003337. PLoS One. 2008. PMID: 18836531 Free PMC article. - Production and pathogenicity of hepatitis C virus core gene products.
Li HC, Ma HC, Yang CH, Lo SY. Li HC, et al. World J Gastroenterol. 2014 Jun 21;20(23):7104-22. doi: 10.3748/wjg.v20.i23.7104. World J Gastroenterol. 2014. PMID: 24966583 Free PMC article. Review. - Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
Whitmill A, Kim S, Rojas V, Gulraiz F, Afreen K, Jain M, Singh M, Park IW. Whitmill A, et al. PLoS One. 2018 Aug 23;13(8):e0202524. doi: 10.1371/journal.pone.0202524. eCollection 2018. PLoS One. 2018. PMID: 30138348 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous